Literature DB >> 17963857

Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents.

Rosa Sabatini1, Giuseppe Orsini, Raffaele Cagiano, Giuseppe Loverro.   

Abstract

BACKGROUND: The aim of this study was to assess the noncontraceptive benefits of two combined oral contraceptives, containing progestins with well-known antiandrogenic properties, in adolescent girls. STUDY
DESIGN: In this prospective observational study, the effects of two formulations containing 30 mcg of ethinyl estradiol combined with 2 mg chlormadinone acetate or 3 mg drospirenone were compared. Six-month data were obtained from 156 sexually active adolescents requiring contraception. We investigated the advantages of these regimens on intermenstrual bleeding, dysmenorrhea, acne and hair and skin disorders. Furthermore, their effects on sexual interest, intercourse frequency and sexual satisfaction were evaluated.
CONCLUSION: Both preparations provided effective contraception, good cycle control and beneficial effects on preexisting hair and skin disorders without effects on body weight. However, the best results were obtained with the formulation containing chlormadinone acetate, with the difference being statistically significant. Furthermore, the contraceptive adherence to teenager expectations and the counseling effectiveness enhancing compliance contribute to a high rate of continuation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963857     DOI: 10.1016/j.contraception.2007.07.002

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2 mg (Belara®): a 13-cycle, observational study in routine clinical practice.

Authors:  Daphnee S Pushparajah; Petra Röhm; Kornelia Höschen; Dagmar Albers; Christina Nowack
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial.

Authors:  Unnop Jaisamrarn; Somsook Santibenchakul
Journal:  Contracept Reprod Med       Date:  2018-04-10

3.  Needs and preferences of women users of oral contraceptives in selected countries in Central and Eastern Europe.

Authors:  Tomas Fait; Dmitry Buryak; Monica-Mihaela Cirstoiu; Eva Luczai; Rafal Janczura
Journal:  Drugs Context       Date:  2018-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.